A randomized, Open label, Cross-over Clinical Trial to Investigate Pharmacokinetics and Drug Interaction of Crestor and Glucodown OR SR in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2018
At a glance
- Drugs Metformin (Primary) ; Rosuvastatin (Primary)
- Indications Atherosclerosis; Cardiovascular disorders; Hypercholesterolaemia; Hyperlipidaemia; Hypertriglyceridaemia; Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Yuhan
- 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.
- 31 Jul 2012 Actual end date changed from Apr 2012 to May 2012 as reported by ClinicalTrials.gov.
- 14 Mar 2012 Status changed from active, no longer recruiting to completed as reported by Korean Clinical Trials Register.